Howard Levy
Chief Tech/Sci/R&D Officer bij AMPIO PHARMACEUTICALS, INC.
Profiel
Howard Levy is currently a Member of the Society of Critical Care Medicine and the Chief Medical Officer at Ampio Pharmaceuticals, Inc. He previously worked as a Medical Director-Acute Care at Eli Lilly & Co., Senior Director-Global Medical Program at CSL Behring LLC, Chief Medical Officer at Inspiration Biopharmaceuticals, Inc., Chief Medical Officer at Sangart, Inc., Chief-Critical Care Medicine at The University of New Mexico, and Associate VP-Clinical Research & Medical at Novo Nordisk, Inc. He also served as the Chief Medical Officer at Catalyst Biosciences, Inc. from 2016 to 2021.
Dr. Levy holds a graduate degree from Carnegie Mellon University and a doctorate from the University of the Witwatersrand.
Actieve functies van Howard Levy
| Bedrijven | Functie | Begin |
|---|---|---|
| AMPIO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 13-10-2021 |
Society of Critical Care Medicine
 Society of Critical Care Medicine Miscellaneous Commercial ServicesCommercial Services The Society of Critical Care Medicine is a non-profit medical organization founded in 1970. The non-profit company is based in Des Plaines, IL. The company promotes the practice of critical care. | Corporate Officer/Principal | - |
Eerdere bekende functies van Howard Levy
| Bedrijven | Functie | Einde |
|---|---|---|
| CATALYST BIOSCIENCES | Chief Tech/Sci/R&D Officer | 15-08-2021 |
Sangart, Inc.
 Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01-01-2011 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Corporate Officer/Principal | 01-01-2008 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Opleiding van Howard Levy
| Carnegie Mellon University | Graduate Degree |
| University of the Witwatersrand | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| AMPIO PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA. | Health Technology |
Sangart, Inc.
Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Society of Critical Care Medicine
Society of Critical Care Medicine Miscellaneous Commercial ServicesCommercial Services The Society of Critical Care Medicine is a non-profit medical organization founded in 1970. The non-profit company is based in Des Plaines, IL. The company promotes the practice of critical care. | Commercial Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
